← Back to Screener
CapsoVision, Inc. Common Stock (CV)
Price$6.01
Favorite Metrics
Price vs S&P 500 (26W)26.01%
Price vs S&P 500 (4W)-22.01%
Market Capitalization$299.53M
All Metrics
Book Value / Share (Quarterly)$0.28
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.49
Price vs S&P 500 (YTD)-47.92%
Gross Margin (TTM)52.92%
Net Profit Margin (TTM)-186.77%
EPS (TTM)$-0.54
10-Day Avg Trading Volume0.13M
EPS Excl Extra (TTM)$-0.54
EPS (Annual)$-1.03
ROI (Annual)-190.91%
Gross Margin (Annual)52.92%
Cash / Share (Quarterly)$0.22
Revenue Growth QoQ (YoY)-66.67%
ROA (Last FY)-139.37%
EBITD / Share (TTM)$-0.55
Operating Margin (TTM)-188.25%
Cash Flow / Share (Annual)$-0.49
P/B Ratio22.59x
P/B Ratio (Quarterly)37.76x
ROA (TTM)-153.84%
EPS Incl Extra (Annual)$-1.03
Current Ratio (Annual)3.77x
Quick Ratio (Quarterly)2.95x
3-Month Avg Trading Volume0.41M
P/S Ratio (Annual)22.10x
Asset Turnover (Annual)0.75x
52-Week High$15.37
EPS Excl Extra (Annual)$-1.03
26-Week Price Return34.75%
Quick Ratio (Annual)2.95x
13-Week Price Return1.86%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)3.77x
Enterprise Value$289.416
Asset Turnover (TTM)0.82x
Pretax Margin (Annual)-186.59%
Cash / Share (Annual)$0.22
3-Month Return Std Dev99.29%
ROE (Last FY)-190.91%
EPS Basic Excl Extra (Annual)$-1.03
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.54
ROI (TTM)-209.79%
P/S Ratio (TTM)22.10x
Revenue / Share (Annual)$0.55
Year-to-Date Return-43.78%
5-Day Price Return-6.97%
EPS Normalized (Annual)$-1.03
Net Profit Margin (Annual)-186.77%
Month-to-Date Return-17.56%
EBITD / Share (Annual)$-1.03
Operating Margin (Annual)-188.25%
EPS Basic Excl Extra (TTM)$-0.54
P/B Ratio (Annual)37.76x
Pretax Margin (TTM)-186.59%
Book Value / Share (Annual)$0.28
Price vs S&P 500 (13W)-1.00%
Beta-1.52x
Revenue / Share (TTM)$0.29
ROE (TTM)-214.23%
52-Week Low$3.43
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.20
4.20
4.20
4.20
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
CVCapsoVision, Inc. Common Stock | 22.10x | — | 52.92% | -188.25% | $6.01 |
MDTMedtronic plc | 3.12x | 3.01% | 65.16% | 17.00% | $86.19 |
MASIMasimo Corporation | 6.12x | 5.95% | 61.90% | 20.30% | $178.39 |
TMDXTransMedics Group, Inc. Common Stock | 6.56x | 88.21% | 59.92% | 17.93% | $115.87 |
LIVNLivaNova PLC Ordinary Shares | 2.64x | 8.24% | 68.04% | 14.09% | $67.12 |
ITGRInteger Holdings Corporation | 1.67x | 11.55% | 27.39% | 11.90% | $90.20 |
AXGNAxogen, Inc. Common Stock | 8.87x | 14.93% | 74.31% | -3.49% | $38.50 |
CNMDCONMED Corporation | 0.88x | 9.77% | 54.59% | 7.46% | $39.08 |
BLFSBioLife Solutions Inc. | 10.79x | 14.87% | 64.56% | -17.26% | $21.50 |
INMDInMode Ltd. Ordinary Shares | 2.51x | 12.45% | 78.54% | 23.05% | $14.65 |
CBLLCeriBell, Inc. Common Stock | 8.77x | — | 87.89% | -65.57% | $21.19 |
About
CapsoVision develops ingestable capsule endoscopy technology for gastrointestinal imaging, enabling earlier detection of colorectal cancer and other GI diseases. The company's platform features multi-camera capsules with LED illumination, onboard memory, and extended battery life for comprehensive visualization. Current commercial product CapsoCam Plus targets the small intestine, while CapsoColon 3D is in development for large intestine imaging.